GGrantIndex
← Leaderboards

Mary Bruce

Battelle Centers/Pub Hlth Res & Evaluatn

Google Scholar ↗PubMed ↗ORCID ↗
$27,703,129
Attributed
$27,703,129
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $13M · FY2011–23
$20M$15M$10M$5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$27,703,129 · 2

By mechanism

N01$27,592,504 · 2
N02$73,557 · 1
N03$37,068 · 1

Top collaborators

No co-investigators on record.

Most similar at Battelle Centers/Pub Hlth Res & Evaluatn

Same institution · by research overlap

Others in their field

Top investigators on “Contracts”

Research focus

ContractsEfficacy TestingServicesEvaluation/TestingVaccinesCommunicable DiseasesFeasibility StudiesProduct DevelopmentImmunogenicitySamplingAssay DevelopmentNovel VaccinesToxicity TestsNational Institute Of Allergy And Infectious DiseaseSafety TestingEmerging Communicable DiseasesEvaluationBioterrorismStandardizationLicensureInfectious Disease ModelPre-ClinicalEbola VaccinesPrograms

Grant awards (46)

Task X14: Evaluation of Ebola Vaccines$6,263
N01 · FY2023 · AI · contact PI
Task X01: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$195,865
N01 · FY2021 · AI · contact PI
Task X1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$191,683
N01 · FY2020 · AI · contact PI
Task X1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$242,066
N01 · FY2019 · AI · contact PI
Task C10: Enhancing Effectiveness of MVA Vector Vaccines$56,492
N01 · FY2019 · AI · contact PI
Task X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing$13,240
N01 · FY2019 · AI · contact PI
Task X10: Ebola Vaccine Immunogenicity and Efficacy Testing$1,130,027
N01 · FY2018 · AI · contact PI
Task X9: Development of Standardized Filovirus Immune Assays and Reagents$655,386
N01 · FY2018 · AI · contact PI
Task X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing$216,270
N01 · FY2018 · AI · contact PI
Task X1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$184,405
N01 · FY2018 · AI · contact PI
Task X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing$280,945
N01 · FY2017 · AI · contact PI
Task X1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$190,878
N01 · FY2017 · AI · contact PI
Task X14: Evaluation of Ebola Vaccines$89,265
N01 · FY2017 · AI · contact PI
Task C07: Plague Antibiotic Treatment Models$9,322
N01 · FY2017 · AI · contact PI
Task X7: Preparedness for Testing Zika Virus Vaccines$2,328,210
N01 · FY2016 · AI · contact PI
Task X7: Preparedness for Testing RSV Vaccines$670,969
N01 · FY2016 · AI · contact PI
Task X10: Ebola Vaccine Immunogenicity and Efficacy Testing$344,576
N01 · FY2016 · AI · contact PI
Task X9: Development of Standardized Filovirus Immune Assays and Reagents$278,413
N01 · FY2016 · AI · contact PI
Task 1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$177,115
N01 · FY2016 · AI · contact PI
Task X14: Evaluation of Ebola Vaccines$157,455
N01 · FY2016 · AI · contact PI
Task X12: Evaluation of Human Tissue Cross-reactivity of Phase I Clinical Trial Serum Samples$105,457
N01 · FY2016 · AI · contact PI
Task C01: Efficacy Testing of Therapeutics Against Inhalational Anthrax in NHPs$11,417
N01 · FY2016 · AI · contact PI
Task X14: Evaluation of Ebola Vaccines$8,942,639
N01 · FY2015 · AI · contact PI
Task X9: Development of Standardized Filovirus Immune Assays and Reagents$1,222,829
N01 · FY2015 · AI · contact PI
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases$737,737
N01 · FY2015 · AI · contact PI
Task X11:Evaluation of Clinical Samples from a Dengue Vaccine Clinical Trial$700,445
N01 · FY2015 · AI · contact PI
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases$550,747
N01 · FY2015 · AI · contact PI
Task X12: Evaluation of Human Tissue Cross-reactivity of Phase I Clinical Trial Serum Samples$268,628
N01 · FY2015 · AI · contact PI
TO X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing$255,693
N01 · FY2015 · AI · contact PI
Task 1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$173,274
N01 · FY2015 · AI · contact PI
Task X5: Challenge Biodistribution Study for Malaria Vaccines$79,802
N01 · FY2015 · AI · contact PI
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases$29,014
N01 · FY2015 · AI · contact PI
Task X9: Development of Standardized Filovirus Immune Assays and Reagents$1,761,782
N01 · FY2014 · AI · contact PI
Task X10: Ebola Vaccine Immunogenicity and Efficacy Testing$1,450,700
N01 · FY2014 · AI · contact PI
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases$380,129
N01 · FY2014 · AI · contact PI
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases$302,399
N01 · FY2014 · AI · contact PI
Task 1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$171,906
N01 · FY2014 · AI · contact PI
Task X5: Challenge Biodistribution Study for Malaria Vaccines$140,013
N01 · FY2014 · AI · contact PI
Task C01: Efficacy Testing of Therapeutics Against Inhalational Anthrax in NHPs$73,557
N02 · FY2014 · AI · contact PI
Task B01: Validation of the MSD Protective Antigen(PA)-ECL Assay$37,068
N03 · FY2014 · AI · contact PI
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases$13,706
N01 · FY2014 · AI · contact PI
Task C08: Vaccine Testing in Monkeypox NHP Model$1,068,747
N01 · FY2011 · AI · contact PI
Task C10: Enhancing Effectiveness of MVA Vector Vaccines$982,091
N01 · FY2011 · AI · contact PI
Task C13: Plague Vaccine Candidates$392,117
N01 · FY2011 · AI · contact PI
Task C07: Plague Treatment Models$310,298
N01 · FY2011 · AI · contact PI
Task C10: Enhancing Effectiveness of MVA Vector Vaccines$122,089
N01 · FY2011 · AI · contact PI